Diabetes

Article	Citations
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking	113
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data	107
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes	97
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases	87
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation	82
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di	78
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes	73
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery	68
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes	62
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)	61
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk	51
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes	51
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings	46
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes	45
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle	44
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education	44
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes	41
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients	41
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity	41
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia	40
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes	40
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells	39
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study	39
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT	38
1641-P: Effect of Specific Weight-Reducing Interventions on Metabolic and Immunological Outcomes in Mice	38

280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents	38
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study	38
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema	38
718-P: A High FODMAP Diet Reduces Glycemic Excursion without Increasing Gastrointestinal Symptoms in Individuals with Prediabetes Treated with Metformin—A Randomized Crossover Controlled-Feeding Trial	37
1358-P: Diabetes Prediction without Blood Tests—The Role of Retinal Imaging and Artificial Intelligence	37
1478-P: Incidence and Glucose Trends among Patients with Acute Stroke and Stress Hyperglycemia—Insights from a Descriptive Analysis	36
99-OR: AgRP Neuron Hyperactivity Drives Hyperglycemia in a Mouse Model of Type 2 Diabetes	36
1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)	35
643-P: Exploring Eating Styles of Older Adults with Type 1 Diabetes (T1D)	35
366-P: Machine Learning Reveals CGM Superiority over Hypoglycemia Awareness Questionnaires in Discriminating Individuals with Severe Hypoglycemia	35
121-OR: Safety, Tolerability, and Metabolic Effects of Once-Weekly GL0034 (Utreglutide) in Individuals with Obesity—A Multiple Ascending Dose Study	35
1823-LB: DiaLOG—A Personalized and Interactive Diabetes Education Platform Empowered with Risk Assessment AI Algorithms and ChatGPT	34
500-P: Causal Effect of SGLT2 Inhibition on Diabetes-Related Retinopathy (DR) and Macular Edema (DME)	34
1635-P: Sex Differences in Skeletal Muscle Mitochondrial Function in Rats Fed a High-Fat/High-Sucrose Diet	33
649-P: Preliminary Outcomes of a Transition Intervention with Adolescents and Young Adults (AYAs) with Type 1 Diabetes (T1D)	33
264-OR: Incorporating Shared Decision-Making to Facilitate Equitable Insulin Pump Use among Pediatric Patients with Type 1 Diabetes	32
261-LB: Hepatocyte Gdf15 Protects against CCL4-Induced Liver Injury Independent of Changes in Feeding and Inflammation	32
105-OR: Single-Cell Multiomic Analysis of the Effect of GIP and GIP-1 Mono- and Multi-agonism on the Hypothalamus and Hindbrain	32
111-OR: Vascular Endothelium-Specific ROCK2 Deficiency Inhibits the Progression of Obesity via Adipocyte Browning	32
431-P: Effects of CB1 Antagonist INV-202 in Patients with Metabolic Syndrome—A Randomized, Placebo-Controlled, Double-Blind Phase 1B Study	31
1268-P: P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes	30
1720-P: Epigenetic Regulator Slug Directly Promotes Beige Adipogenesis	30
248-OR: Diabetes Remission after Gastric Bypass Is Characterized by Upregulation of LXR and Antioxidant-Related Pathways in Jejunum	30
1278-P: Changes in Cardiovascular Disease (CVD) Incidence Due to Remission of Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)	29
603-P: Diabetes Distress Is Associated with Poor Glycemic Control after Islet Autotransplantation	29
475-P: Intermittent Hypoxia Increased the Expression of Intercellular Adhesion Molecule-1 and Endothelial Cell–Specific Molecule-1 in Vascular Endothelial Cells via the Downregulation of MicroRNA-181a	29
1117-P: Comparison between Glucose Management Indicator (GMI) with HbA1c among Patients in a Hybrid Therapeutics Care Model	29
1811-PUB: Real-World Safety of the Combined Use of Dapagliflozin and Metformin in Type 2 Diabetes Mellitus Patients in China—Post Hoc Analysis of the DONATE Study	28
1616-P: MENTSH—A Mitochondrial Microprotein and SNP-Associated with Diabetes in People with Native American Ancestry	28
1117-P: Variability in Glycemia Measured by CGM in Children and Young Adults with Acute Recurrent or Chronic Pancreatitis	27
11-PUB: Transitioning from Dulaglutide to Tirzepatide Improves Glycemic Control in Patients Undergoing Hemodialysis with Type 2 Diabetes—An Assessment by Continuous Glucose Monitoring	27
1687-P: Similarities and Differences between Metabolically Unhealthy Lean and Metabolically Unhealthy Obese Individuals	27
74-PUB: Knowledge, Attitude, and Practice of Individuals with Obesity—Insights from a Large Nationwide Survey	27
1574-P: FoxO1 Links Insulin Resistance to Hepatic Inflammation and Catalyzes the Evolution of Benign Steatosis to Nonalcoholic Steatohepatitis	27
1416-P: Differences in Treatment and Metabolic Outcome between Males and Females Living with T2D—Results from the Multicenter DPV Registry	27
1463-P: Heterozygous Variant in NFKB1 Presenting with Autoantibody-Negative (AbNeg) Insulin-Dependent Diabetes (IDDM)	26
546-P: Comparing Diabetes Risk Perception between Latina and White Women with T2D Risk Factors	26
665-P: Association between Housing Insecurity and Hemoglobin A1c among Adults with Type 2 Diabetes—A Cross-Sectional Analysis of the All of Us Research Program	25
1792-LB: Long-Term Impact of Glucose Status on Risk of Restenosis after Percutaneous Transluminal Coronary Angioplasty—A Six-Year Follow-up Study	25
217-LB: Heterogeneity of Single Cells Obtained from Peripheral Blood Mononuclear Cells Collected from Youth with Recent-Onset Type 1 Diabetes	25
201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes	25
1101-P: Patient-Centered Weight Management Clinical Decision Support—A Proof-of-Concept Study	25
134-OR: NOD1 Deletion in Skeletal Muscle Protects against Palmitate-Induced Insulin Resistance	25
1410-P: Impacts of COVID-19 on Underserved Communities with Diabetes	24
75-PUB: The Sartorius Fat Fraction Is Independently Associated with Myocardial Fibrosis in Chinese Patients with Obesity	24
437-P: Coronary Calcium Score and Cardiovascular Events in Ketosis-Prone Diabetes Compared with T2DM	24
438-P: Very-Low-Dose Metformin Can Safely Improve Glycemic Control in Type 2 Diabetic Patients Receiving Maintenance Hemodialysis (HD)	24
1499-P: Diabetes Technology Use and Acute Complications in Type 1 Diabetes—Racial Disparities Still Persist	24
1692-P: Metabolic Assessment of Semaglutide (a GLP-1R Agonist) and Tirzepatide (a GLP-1R/GIPR Coagonist) in Diet-Induced Obese (DIO) Mice	24
410-P: Development and Validation of a Risk Score for Predicting the Initiation of Dialysis in People with and without Diabetes Mellitus	24

1821-PUB: Relationship between Time in Range and Glucose Management Indicator in Adolescents and Children with Type 1 Diabetes Mellitus	24
658-P: Evaluating Financial Incentives as a Tool to Increase Medication Adherence—A Systematic Review and Meta-analysis	23
721-P: Mechanisms of Relapse after Lifestyle Intervention–Induced Remission of Prediabetes	23
1767-P: Body Composition and Body Mass Index among People with and without Diabetes—A National Analysis, 2011–2018	23
1044-P: Advancing Quality Improvement Culture among 27 Pediatric and Adult Diabetes Centers	23
1797-LB: Detection of Potential Therapeutic Target Associated with Coronary Artery Disease in Type 2 Diabetes Patients—System Biology Approach	22
978-P: Correlation between Continuous Glucose Monitoring Metrics, Oral Glucose Tolerance Test, and HbA1c in Individuals with Impaired Glucose Tolerance	22
1998-LB: Previously Frozen Beta-Cell Transcriptional Response to Cytokine Treatment Mirrors That of Fresh Beta Cells	22
19-OR: Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)	22
1041-P: Assessing the Value of Managing Diabetic Kidney Disease from a U.S. Health Care Perspective	22
1899-LB: The Predictors and Management of Eating Disorders in Adult Patients with Type 1 Diabetes Mellitus	22
1804-LB: Serum Spexin Level Is Negatively Associated with Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes	22
600-P: The Healthy Gut Diet for Preventing Gestational Diabetes Improves Dietary Intake and Diet Quality	22
1435-P: Improvements in Metabolic Health from Spanish-Delivered Care Are Similar to English-Delivered Care in a Carbohydrate-Restricted Nutrition Therapy Program	21
422-P: Type 2 Diabetes and the Individual Perception of Risk for Cardiovascular Death in Coronary Artery Disease Patients	21
391-P: Targeted Deletion of Rho-Associated Coiled-Coil–Containing Protein Kinase 2 in Kidney Tubules Suppresses Expression and Function of Mineralocorticoid Receptor in Mice	21
63-PUB: Diabetes Control and Complications in South India—Three-Year Results of LANDMARC Trial	21
Comment on Carrasco et al. Spatial Environment Affects HNF4A Mutation-Specific Proteome Signatures and Cellular Morphology in hiPSC-Derived β-Like Cells. Diabetes 2022;71:862–869	21
1928-LB: Understanding the Burden of Digital Care—Field Testing the TBQ+D in Patients Living with Diabetes	21
842-P: Improvement in Time in Range after Smart Insulin Pen Initiation in Austria	21
252-OR: Associations of Serum Lipid Profiles with Diabetic Macular Edema and Retinal Structural Alterations	21
2101-LB: Recruitment Strategies to Increase the Reach of the National Diabetes Prevention Program in Rural Populations	21
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics	21
1777-P: Three-Dimensional Imaging Reveals Pancreatic Islet Fast Calcium Wave Origin Formation	21
507-P: Trajectories of Inflammatory Proteins over Diabetic Wound Healing Course	21
Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure	21
827-P: Patient-Reported Outcomes with Use of Inhaled Technosphere Insulin (TI)	21
783-P: Elucidating the Benefit of Pump-Delivered Subcutaneous GLP-1R Agonist—Exploratory Study in the DIO Mouse	21
594-P: Exercise Timing Has Limited Effect on Glycemic Profile in a Cluster of Well-Controlled Youth with Type 1 Diabetes	20
1844-LB: Community Engaged Research—Lessons Learned from a Pediatric Type 1 Diabetes Study	20
933-P: Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes—A Randomized Controlled Trial (DMVascular Study)	20
932-P: MiniMed 780G System Use in a Real-World United States (U.S.) Population Aged 65 Years and Older with Diabetes	20
1066-P: Sleep Habits and Their Impact on CGM Parameters in Patients with Type 1 Diabetes	20
385-P: MDSC-Mediated Neutrophil Extracellular Traps–Based Targeting of Diabetic Vasculopathy—Dapagliflozin for Vascular Remodeling in Diabetic Nephropathy	20
1127-P: 4T Study—Early CGM Initiation and Tighter Glucose Targets Improves A1C in Youth with T1D	20
999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A	20
770-P: Efficacy and Safety of Tirzepatide in Participants Who Achieved Fasting Serum Glucose Targets at 52 Weeks in SURPASS-3 and SURPASS-4	20
1422-P: Understanding COVID-19 Impacts among Underserved Adults with Diabetes Using the Social-Ecological Model	20
1629-P: Association between Dyslipidemia and Myosteatosis Evaluated by Abdominal Computed Tomography	20
1588-P: Translatable Modeling of Glucagon Actions in Human iPSC-Derived Hepatocytes Uniquely Predicts Differential Clinical Responses to Glucagon Analog Agonist Molecules	20
632-P: Beta-Cell Function Is a Stronger Predictor Than Insulin Resistance for Development of Type 2 Diabetes in Obese Indian Population—A Matched-Pair Cohort Analysis	19
1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance	19
1571-P: Plasma FGF5 Concentration Correlates Better with Hepatic Steatosis, Blood Glucose, and Specific Plasma Free Fatty Acids than with Other Tissue Fat Accumulation	19
1526-P: A Clinically Optimized Genetic Prediction Model for Differentiating Type 1 and Type 2 Diabetes	19
2188-LB: Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity	19
727-P: A Phase 3 Evaluation of CAMP-Biased GLP-1 Analog Ecnoglutide vs. Dulaglutide in Adults with Type 2 Diabetes	19
1706-P: Software-Aided Self Selection of Weight Loss Diet Plan for Facilitating Diabetes Management in Primary Care	19
607-P: Associations of Gut Microbiome with Glycemic Control in a Carbohydrate-Restricted, High-Protein Diet for Type 2 Diabetes Mellitus	19
571-P: Theory-Based Design of a Nutrition-Focused Approach at CGM Initiation for People with T2D	19
1452-P: Financial Toxicity and Cost-Related Nonadherence (CRN) in Adults with Type 1 Diabetes (T1D)—Prevalence and Associations with Social Determinants of Health	19
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity	19
79-OR: Targeted Erasure of DNA Methylation by TET3 with C/EBPδ Rewires Adipogenic Execution for Energy Metabolism	19
1223-P: Frequency and Predictors of Level 2 Time Above Range (TAR) in Older Adults with Type 2 Diabetes on Insulin Therapy—Data from the HYPOAGE Prospective Study	18
1713-P: Deletion of SGK1 in Smooth Muscle Cells Induces Adipose Tissue Beiging and Differential Secretion of Vasokines	18
1807-PUB: Monocarbonyl Curcumin Analogs C66 and B2BrBC Improve Redox Status in Streptozotocin-Induced Diabetic Rats	18
227-LB: Kynurenine Pathway Is Associated with Preservation of Beta-Cell Function in Autoimmune Diabetes	18
1760-P: Mining Animal Venoms as a Source of Insulinotropic Peptides for Potential Diabetes Therapy	18
1908-LB: A Machine-Learning Framework to Quantify Postprandial Glucose Responses in Gestational Diabetes	18
1707-P: Real-World 12-Month Weight Loss Outcomes of Tirzepatide—The Mayo Clinic Experience	18
1762-P: Regional Body Fat Distribution Is Associated with Higher Risk for Sleep Deficiency and Sleep Disorders	18
1726-P: Comparison of Subcutaneous, Visceral, Liver, and Muscle Fat Depots in Relation to Diabetes Risk—A Prospective Cohort Study	18
1126-P: Does the Use of a Case Manager Matter in Diabetes Care?	18
2060-LB: Benchmarking AI in Type 1 Diabetes Management—How Well Do Generative AI Platforms Follow ADA SOC?	17
2111-LB: Discrepancies between Creatinine-Cystatin C-Based and Creatinine-Based eGFR and Their Association with Vascular Complications in Adults With Diabetes—The China Diachronic Study	17
283-OR: Adipose Stromal Cells Increase Insulin Sensitivity and Decrease Liver Gluconeogenesis in a Type 1 DM Mouse Model	17
296-OR: Glucagon and Insulin Cross Talk Regulates Hepatic Glycogen Metabolism	17
1635-P: Short-Term Production of Circulating Triglycerides Is Positively Associated with Triglyceride Concentration in Adolescents with and without MASLD	17
429-P: The Difference between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate in Relation to Carotid Plaque Score in Patients with Type 2 Diabetes	17
94-OR: Pathogenic Action of GAD65 Autoantibodies on Islet Function in Type 1 Diabetes	17
2176-LB: Circadian Clock Regulation of HIF1a-Dependent Skeletal Muscle Metabolism during Diet-Induced Obesity	17
32-PUB: Glycemic Variability after Initiation of SGLT2 Inhibitors in CKD	17
726-P: Medication Adherence among American Indians with Type 2 Diabetes—Assessing the Quality of Electronic Health Record Data within a Large Tribal Health Care System	17
17-PUB: Glucagon-Like Peptide 1 Receptor Agonists' Heterogeneous Treatment Effects on Asthma Exacerbations—A Causal Machine-Learning Analysis	17
167-LB: Knowledge Retention and Glycemic Control in Participants of Kids in Control of Food (KICk OFF) Program—Virtual vs. On-Site	17
1126-P: Smart Insulin Pens—A Randomized, Crossover Pilot Trial Assessing Glycemic Control and Diabetes-Related Burdens in Adolescents and Emerging Adults with Diabetes	17
140-OR: Adoption of State-Level Complete Streets Legislations and U.S. Prevalence of Obesity	17
1661-P: Exogenous Oxytocin Has No Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals with Obesity	17
1040-P: Feasibility and Performance of Continuous Glucose Monitoring (CGM) to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit (CV-ICU)	17
785-P: Preclinical Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Assessments of Sustained-Released Formulation of Once-Monthly Injectable Semaglutide (PT403)	16
671-P: Development of Novel Infrastructure for Diabetes Distress Screening in the Electronic Health Record	16

72-OR: A Novel Multiancestry Polygenic Score Improves T1D Risk Prediction in Non-European Populations	16
Comparison of β-Cell Function and Insulin Sensitivity Between Normal-Weight and Obese Chinese With Young-Onset Type 2 Diabetes	16
Perilipin 1 Antibodies in Patients With Acquired Generalized Lipodystrophy	16
1-PUB: Impaired Kidney Function in Diabetic Patients—A Warning	16
1946-LB: Patterns of Insulin Discontinuation in Youth with New-Onset Type 2 Diabetes	16
2059-LB: NA-931, a Novel Triple IGF-1/GLP-1/GIP Incretin Receptor Agonist Reduces Body Weight and Improves Metabolic Profile in DIO Mice	16
1801-LB: Discovering Novel Cathepsin L Inhibitors Using Artificial Intelligence for Diabetic Nephropathy	16
238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years	16
507-P: Human Liver-Specific Regulation of Lipogenesis by Long Noncoding RNA hLMR1	16
1736-P: Exploring Intrinsic Features of Human Pancreatic a- and ß-Cell Physiology Using Pseudoislets	16
1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective	16
10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease	16
Expression of Concern. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydr	15
967-P: The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy	15
Protein Markers of Diabetes Discovered in an African American Cohort	15
1809-PUB: Painful Diabetic Neuropathy—Patients Treated with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Experience Significant Reductions in A1C and Weight	15
849-P: Antidiabetic Effects of TLC-3595, a Selective ACC2 Inhibitor, in ZDF Rats	15
68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention	15
1492-P: IL-8/CXCL8 May Identify a New Type 1 Diabetes Endotype	15
Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals	15
280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions	15
Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes	15
612-P: The Effectiveness of Lifestyle, Metformin, or Dietary Supplements for the Prevention of Gestational Diabetes Mellitus (GDM) by Participant Characteristics—A Systematic Review and Meta-analysis	15
218-OR: Time of Exercise Affects Nocturnal Hypoglycemia after Exercise in Adults with Type 1 Diabetes (T1D)—Results from the T1D Exercise Initiative (T1DEXI) Study	15
204-OR: An Early Immune Signature in Prediabetes Can Predict Progression to Type 2 Diabetes	15
1081-P: Trends in Treatment Goal Attainment of Cardiovascular Risk Factors in Chilean Adults with Diabetes Mellitus—Results from the National Health Survey 2016–2017	15
1764-P: Assessing Gene Expression Profile and Insulin Secretion in Human Beta Cells (EndoC-BH3) under Glucose Exposure	14
1508-P: Knowledge of Alzheimer’s Disease and Related Dementia and Associated Factors among Middle-Aged and Older Adults with Type 2 Diabetes	14
1758-P: Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline BMI: COMBINE 1–3	14
1625-P: Smartphones Everywhere but Apps Rarely Used for Carb Counting: Insights from Adults with Type 1 Diabetes	14
1423-P: Triple Target Achievement in Type 2 Diabetes	14
1726-P: Baseline Clinical and Proteomic Predictors of Glycemic Deterioration in SELECT	14
1430-P: Sex-Dependent Vascular and Proteomic Remodeling in Type 1 Diabetic Mice Fed a Western Diet	14
1373-P: Significant Synergistic Effects in Diabetic Kidney Disease by HDM1010	14
1227-OR: RAY1225, a Biweekly Biased GLP-1/GIP RA for Weight Management: A Phase 2 Trial in Chinese Overweight/Obese Adults (REBUILDING-1)	14
1777-P: Early Real-World Liver Biomarker Changes among Resmetirom-Treated MASH Patients, with and without T2DM: A Descriptive Cohort Study	14
750-P: Association of Glucagon-Like Peptide 1 Receptor Agonists with Incident Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes	14
1510-P: Systematic Literature Review and Meta-Analysis: Social Media Use for Self-Management Education and Support for Type 2 Diabetes Mellitus	14
1646-P: Prevalence of Cardiometabolic Risk Factors in Postpartum WIC Participants Screened for a Lifestyle Intervention Trial	14
1261-OR: Molecular Risk Scores Enhance Type 2 Diabetes (T2D) Prediction beyond Hemoglobin A1c (HbA1c) and Body Mass Index (BMI) across Diverse Clinical Contexts	14
1401-P: Geographic Differences in Diabetes Prevalence and Testing for Kidney Disease at U.S. Federally Qualified Health Centers	14
1854-P: MiniMed 780G System Users with Spanish or English Language Settings Achieve Similar Glycemic Outcomes	13
1912-P: A Novel ATP-Independent Enzymatic Cycling System for Glucose Removal Enables Accurate Quantification of 1,5-anhydroglucitol	13
2531-P: Peripheral Glucose-Dependent Insulinotropic Peptide Receptor (GIPR) at the Intersection of Obesity and Fatty Liver Disease	13
1294-OR: Efruxifermin Improved Liver Disease and Insulin Sensitivity in Participants with Type 2 Diabetes and Metabolic Dysfunction–Associated Steatohepatitis (MASH) Cirrhosis in the SYMMETRY Trial	13
2072-P: Metabolic Bariatric Surgery in Korean Adolescents with Severe Obesity	13
2221-P: Prediabetes Prevalence and Diabetes Incidence according to Different Prediabetes Definitions: Implications for Diabetes Prevention	13
1571-P: The Diabetes Tune-Up Group: Treating Diabetes Distress in Black and African American Women with T2D	13
1849-LB: Social Determinants of Health and Early-Onset Type 2 Diabetes—A Qualitative Study	13
1617-P: Outcomes from a Pilot Behavioral Lifestyle Intervention for Youth with Type 1 Diabetes	13
1071-OR: Improving Diabetes Eye Disease Screening Rates in Under-Resourced Communities	13
14-PUB: Nutritional and Lifestyle Interventions in the Management of Diabetes in the United States: A Scoping Review	13
2222-P: Prospective Validation of AI for Detecting Misclassified Adult Type 1 Diabetes: Insights on Precision, Clinical Workflows, and Adoption	13
19-PUB: Real-World Outcomes of Adjunct GLP-1 Receptor Agonist Therapy in Adults with Type 1 Diabetes: A Retrospective Cohort Study	13
1170-OR: CGM for Adults with Type 2 Diabetes Not on Insulin Therapy: The CONNECT Randomized Controlled Trial	13
1596-P: Coexpressed microRNAs Identify Biological Pathways Associated with Psychometabolic Risk in Women	13
1550-P: Domain-Specific and Dose-Response Effects of a New Digital Intervention for Diabetes Distress in Families of School-Aged Children Living with Type 1 Diabetes (T1D)	13
1298-OR: CGM-Derived Disposition Index in Stage 1 Type 1 Diabetes (T1D)	13
2138-P: A Novel Strategy for Optimizing Preconception Medication Choices in Women with Early-Onset Type 2 Diabetes	13
1902-P: Continuous Glucose Monitoring Metrics Predict ≥40% EGFR Decline among Adults with Type 1 and Type 2 Diabetes	13
2140-P: Differential Fatty Acids in Human Milk from Individuals with Gestational Diabetes	12
2894-LB: Assessing Long-Term Glycemic Control Using Continuous Glucose Monitoring Data with a Machine Learning Algorithm	12
1862-P: Medicaid Beneficiaries with Type 1 and Type 2 Diabetes Achieve ADA-Recommended Glycemic Targets Using the MiniMed 780G System	12
2308-P: Disparities in Diet Quality of Retail Food Purchases among Households That Include a Person with Diabetes	12
2044-P: Using the Consolidated Framework for Implementation Research (CFIR) to Identify Barriers and Facilitators to Adoption of a Digital Quality Improvement Portal across a National Type 1 Diabetes	12
2467-P: Characterizing the Diurnal Variability of Insulin Sensitivity and Beta-Cell Responsivity in People with Type 2 Diabetes	12
2434-P: Identification of a Cell-Autonomous Effect of KAT8 in Adipocytes	12
2345-P: Risk Factors for Postoperative Glucose Metabolic Disorders following Pancreatic Surgery: A Single-Center Cohort Study	12
2011-P: Demographic Predictors of Stigmatizing Beliefs toward Type 1 and Type 2 Diabetes in Medical Students	12
2854-LB: Efficacy and Safety of CU01-1001 in Patients with Diabetic Kidney Disease: Significant Reduction in Urine Albumin–to–Creatinine Ratio (uACR)	12
1988-P: Beyond Glycemic Control: Health-Related Quality-of-Life Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes	12
1497-P: Culturally Adapting a Cardiometabolic Self-Management Education and Support (SMES) Intervention	12
1852-P: Real-World Efficacy of the iLet Bionic Pancreas in Users with Type 1 and Type 2 Diabetes during the First Two Years of Commercial Availability	12
2331-P: Prevalence of Diabetes in Youth Aged 0–17 Years in a Large, Integrated Health Care Delivery System in California, 2018 and 2024	12
2001-P: From Knowledge to Action: A Quality Improvement Initiative to Guide Home Ketone Management in Pediatric Diabetes	12
2915-LB: Evaluating the Impact of a Pharmacy-Led Glycemic Stewardship Service on Severe Hyperglycemia and Inpatient Glycemic Control	12
37-PUB: Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors among Pregnant Women with Diabetes at Time of Conception Stratified by Socioeconomic Factors	11
3053-LB: Loss of Miro1 Improves Whole-Body and Skeletal Muscle Insulin Sensitivity in Mice with Obesity and Hyperglycemia	11
32-PUB: Patient-Reported Reasons for Nonuse of Diabetes Technology in Pediatric Type 1 Diabetes	11
2097-P: Age at Type 1 Diabetes Diagnosis Is an Independent Risk Factor from HLA for Development of Type 1 Diabetes in First-Degree Relatives	11
Rsk4 Mediates Brain FGF19 Signaling to Constrain Diet-Induced Obesity in Mice	11
2197-P: The Impact of Lipid-Modifying Therapy (LMT) on 30-Year Non-HDL Cholesterol and Cardiovascular Disease (CVD) Is Similar by Sex in Type 1 Diabetes (T1D)	11
2807-LB: Behaviorally Informed My Control! Intervention with Continuous Glucose Monitoring for Adults with Prediabetes: Results from Two Trials	11
3037-LB: Androgen Receptor Action in Arcuate Nucleus Impairs Estrogen Insulin-Sensitizing Actions and Insulin Suppression of Hepatic Glucose Production in Female Mice	11
41-PUB: When the Eyes and Kidney Don't Align: Retino-Renal Dissociation in Type 2 Diabetes Mellitus	11
2067-P: Effect of Phentermine/Topiramate on BMI Reduction in Adolescents with Youth-Onset Type 2 Diabetes and Obesity	11
3074-LB: Inhibition of VDAC1 Oligomerization Regulates Energy Balance through Hypothalamic STAT3 Activation in Mice	11
3076-LB: Coupling Lysosomal and Mitochondrial Lipid Metabolism in Adipose Tissue Macrophages as a Therapeutic Strategy in Obesity	11
2984-LB: Gender Differences in Diabetic Ketoacidosis	11
2624-P: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orforglipron: A Multiple Dose Titration Study in Chinese Participants with Obesity or Overweight with Weight-Related Comorbiditi	11
1893-LB: Effects of High Fibers and Probiotics Supplements Diet and Lifestyle Intervention in Type 2 Diabetes or Prediabetes—A Randomized, Double-Blind, Placebo-Controlled Pilot Trial	11
Upregulation of Acid-Sensing Ion Channel 1a in the Anterior Cingulate Cortex by TNF-α/NF-κB Pathway Contributes to Diabetes-Related Pain	11
A Randomized Controlled, Double-Masked, Crossover Study of a GPR119 Agonist on Glucagon Counterregulation During Hypoglycemia in Type 1 Diabetes	11
2474-P: Comparable Hepatic Benefits with Differential Effects on Triglycerides and Glycemic Control: A 24-Week Prospective Study	11
Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells	11